D iabetes mellitus causes atherosclerosis of peripheral as well as coronary arteries and is a major risk factor for the development of coronary artery disease. Because of this association, it is not surprising that myocardial infarction is common in diabetes. In addition, studies in rats have shown a diabetes-induced cardiomyopathy in the absence of coexisting coronary atherosclerosis.1 However, it has not been possible to determine clinically whether this metabolic disorder has independent direct effects on the ability of the myocardium to tolerate ischemia.
To more carefully evaluate the possible cardiac consequences of the metabolic abnormalities of diabetes, animal models of chemically-induced diabetes have been developed. Previous studies with these models have shown that diabetic myocardium exhibits a variety of abnormalities that may influence ischemic injury, including depressed Na+-Ca2' and Na+-HW exchange activities,2,3 decreased sarcoplasmic reticular Ca 2 pump activity,4 5 and elevated antioxidant defenses. 6 Furthermore, whereas diabetic myocardium is less responsive to 13-adrenergic stimulation,5,7 it may be more responsive to a-adrenergic stimulation.8,9
The tolerance of diabetic myocardium to ischemia also has been examined. But the differing protocols and variety of end points of ischemic injury have yielded confusing data. Earlier work using glucose-perfused diabetic rat hearts and evaluating the degree of ischemic injury by either recovery of mechanical function or changes in energy metabolism concluded that diabetes had an adverse effect on the ischemic heart.10'1' Others have reported that ischemia-reperfusion injury is not significantly different in normal and diabetic animals, '2 whereas the most recent studies suggest that diabetic hearts are more resistant to ischemia. Tani and Neely13 noted that diabetic rat hearts had better functional recovery after global ischemia than hearts from normal animals,13 and Kusama and his colleagues14 demonstrated that diabetic rat hearts are less susceptible to reperfusion-induced arrhythmias.
Diabetes can be subdivided into insulin-dependent (IDD) and non-insulin-dependent (NIDD) types, and the response of each variety to ischemia is not necessarily the same. Previous studies evaluating susceptibility of the diabetic heart to ischemia used a chemically induced IDD model and were performed in vitro.'0-14
The end point of these studies was functional recovery or arrhythmias instead of infarction. The present study was designed to directly assess the ability of the diabetic heart to tolerate an ischemic insult in situ by measuring myocardial infarct size after regional ischemia in NIDD and age-matched control rats. Our data in this study indicate that hearts of NIDD animals are more resistant to infarction than normal hearts and that ischemic preconditioning can further protect the myocardium of NIDD rats.
Methods

Animals
The rat model of chemically induced NIDD was produced as described previously.1 Briefly, male Wistar rats at 2 days of age were injected intraperitoneally with 90 mg/kg of streptozotocin dissolved in 0.1 mL of citrated buffer, pH 4.5. Control littermates received sham injections of the citrate buffer. These animals were maintained ad libitum on water and Purina rat chow. All NIDD rats and the age-matched control rats were studied at 11 to 12 months of age. Methods to measure plasma glucose and insulin have been previously reported.5
Surgical Preparation ofAnimals
The rat was anesthetized with sodium pentobarbital (60 mg/kg IP), and the trachea was intubated through a tracheotomy. Mechanical ventilation was achieved with a positive-pressure respirator (MD Industries, Mobile, Ala) using 100% oxygen, a tidal volume of 8 mL, and a rate of approximately 50 breaths per minute. The respiratory rate was adjusted if necessary to keep the arterial blood pH within the normal range. The left carotid artery and jugular vein were cannulated for blood pressure monitoring and administration of additional anesthetic as required, respectively. The heart was exposed through a left thoracotomy in the third intercostal space, and the pericardium was opened. A 2-0 silk thread was passed around the left coronary artery close to its origin with a taper needle, and the ends of the suture were passed through a small vinyl tube to form a snare. In several NIDD rats, a catheter was inserted into the left atrium for injection of radioactive microspheres. The coronary artery was occluded by pulling the snare. Myocardial ischemia was confirmed by the appearance of regional cyanosis. Reperfusion was achieved by releasing the snare and confirmed by observation of visible hyperemia over the surface.
Measurement of Infarct and Risk Zone
At the end of each experiment, the heart was quickly removed and mounted on a Langendorff apparatus, where it was flushed with room-temperature saline for 1 minute. The snare was tightened, and a 0.5% suspension of 1-10 ,um zinc-cadmium fluorescent particles (Duke Scientific, Palo Alto, Calif) was infused into the perfusate to mark the ischemic (risk) zone as the nonfluorescent tissue. The heart was weighed and frozen, then sliced into 2-mm thick sections. The slices were incubated in 1% triphenyl tetrazolium chloride (TTC) in pH 7.4 buffer for 15 minutes. Experimental Protocols This study evaluated six groups of animals; the protocol is shown in Fig 1. The animals were not fasted and were randomly assigned to groups. Groups 1 and 2 consisted of age-matched normal and diabetic rats subjected to a 30-minute coronary artery occlusion followed by 120-minute reperfusion. Groups 3 and 4 were the same as groups 1 and 2 except that the ischemic time was extended to 45 minutes. In the fifth group, diabetic rats underwent ischemic preconditioning before the 45-minute ischemia with three cycles of 5-minute ischemia/5-minute reperfusion. In the sixth group, myocardial collateral blood flow was measured in diabetic rats.
Statistics
All results are expressed as group mean±SEM. The significance of differences was determined by a one-way ANOVA and Scheffe's post hoc test. Significance was accepted at a value of P<.05. 310±19   89+12   311±18  76±14  298±29  PC3+45-minute NIDD  81+9  334+15  78+12  337±17  68±12  302±30 MBP indicates mean arterial blood pressure; HR, heart rate; bpm, beats per minute; NIDD, non-insulin-dependent diabetes; PC3, three cycles of preconditioning (5-minute ischemia/5-minute reperfusion).
*Hemodynamic data during ischemia and reperfusion were measured at the end of ischemia and 60-minute reperfusion, respectively. Animal studies on the tolerance of myocardium to ischemia in IDD models have provided contradictory data.10-14 In previous investigations, hyperglycemia characteristic of IDD was not a factor affecting outcome, since all of those studies were performed in vitro and therefore normal and diabetic hearts were perfused with the same buffer. In the present study, we used an NIDD rat model. Although this study was done in situ, we do not believe that hyperglycemia contributed to the outcome in these experiments either. Diabetes in these animals resembles NIDD in humans in that fasting insulin and blood glucose levels are normal and that nonfasting insulin and blood glucose levels are only slightly elevated.' Moreover, because the ischemia is a no-flow type, myocardial glucose utilization in these animals will be negligible irrespective of blood glucose levels.
What then are the possible mechanisms of the cardioprotection observed in NIDD rats? Previous studies have shown that there are several factors that can influence myocardial infarction. Coronary collateral flow is an important determinant of the size of infarcts. From early studies of experimental myocardial infarction in dogs, it was found that the size of infarcts is inversely related to blood flow to the ischemic tissue.20-22 Since our study involved animals in which diabetes had been induced 11 to 12 months previously by streptozotocin injection, it was considered possible that sufficient coronary collaterals could have developed in our diabetic rats to affect infarct size despite the fact that normal rat hearts are poorly collateralized.23 However, our results indicate that collateral blood flow in NIDD rats is <1% of normal myocardial flow, a level that would be expected to 49 Lactate accumulation in these NIDD animals might be expected to be lower during ischemia and possibly account for the protection observed. However, lactate accumulation during no-flow ischemia is dramatically affected by the rate of glycogenolysis and amount of glycogen stores, which are approximately the same in NIDD and nondiabetic hearts.49 Furthermore, Tani and Neely13 reported that at comparable levels of lactate and pH, hearts from IDD rats demonstrated greater functional recovery after ischemia than normal hearts. It is not clear whether this latter observation can be extrapolated to NIDD rats.
Our data show that preconditioning can reduce infarct size in NIDD rats. Preconditioning is a dramatic phenomenon that limits myocardial infarction as in normal hearts. Brief episodes of myocardial ischemia before a prolonged ischemic period actually cause less infarction than if only the prolonged ischemia had occurred. The mechanism of ischemic preconditioning is currently unknown. Although NIDD limits myocardial infarction by an amount comparable to that seen in preconditioned normal rats,15'50 ischemic preconditioning provided an added increment of protection. It is not clear whether the cellular changes resulting in protection in NIDD rats are amplified by superimposed ischemic preconditioning or whether the latter causes a further effect by an unrelated mechanism. Future investigations will help to distinguish between these two possibilities.
Conclusions
We have found that hearts from rats with streptozotocin-induced non-insulin-dependent diabetes had less necrosis after coronary occlusion than age-matched control rat hearts. The mechanism of this protection is not yet apparent (and is not related to development of collaterals) but could offer important insights into the biochemical reactions that determine irreversibility of cellular damage. We can further reduce necrosis by preconditioning diabetic hearts.
